Peculiarities of surgical tactics of patients with thymus tumors

K. Ponomarova
{"title":"Peculiarities of surgical tactics of patients with thymus tumors","authors":"K. Ponomarova","doi":"10.21303/2585-6634.2021.002150","DOIUrl":null,"url":null,"abstract":"The aim of the study: to study retrospective analysis results of the surgical treatment of thymus tumours for predicting long-time results. \nMethods. Study included 35 patients who were treated at the Department of Thoraco-abdominal Surgery from September 2019 to May 2021. The control group included 20 patients with SVCS were treated with conventional techniques, while the experimental group included 15 patients who underwent a novel bypass surgery developed by us. \nResults. The venous bypass was mandatorily complemented with cytoreduction. Complications in the post-operative period were reported from the experimental group and included auriculo-subclavian bypass thrombosis, post-operative complications were reported in the control group including haemorrhage from the sternotomy wound in 1 (3.3 %) case, superior vena cava thrombosis in 2 (6.6 %) cases, pneumonia in 2 (6.6 %). The relative risk of complications and lethal outcome was calculated for patients from both groups. It was found that the risk of complications was twice as high in the control group as in the experimental group (standard error of relative risk equals 0.64). \nConclusion. The first mandatory step of the radical surgery in patients with thymomas with SVC invasion should be the auriculo-jugular and auriculo-subclavian bypasses, which can reduce the relative risk of post-operative complications by a factor of the risk of lethal by a factor of 3.5","PeriodicalId":33846,"journal":{"name":"Technology Transfer Innovative Solutions in Medicine","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology Transfer Innovative Solutions in Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21303/2585-6634.2021.002150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of the study: to study retrospective analysis results of the surgical treatment of thymus tumours for predicting long-time results. Methods. Study included 35 patients who were treated at the Department of Thoraco-abdominal Surgery from September 2019 to May 2021. The control group included 20 patients with SVCS were treated with conventional techniques, while the experimental group included 15 patients who underwent a novel bypass surgery developed by us. Results. The venous bypass was mandatorily complemented with cytoreduction. Complications in the post-operative period were reported from the experimental group and included auriculo-subclavian bypass thrombosis, post-operative complications were reported in the control group including haemorrhage from the sternotomy wound in 1 (3.3 %) case, superior vena cava thrombosis in 2 (6.6 %) cases, pneumonia in 2 (6.6 %). The relative risk of complications and lethal outcome was calculated for patients from both groups. It was found that the risk of complications was twice as high in the control group as in the experimental group (standard error of relative risk equals 0.64). Conclusion. The first mandatory step of the radical surgery in patients with thymomas with SVC invasion should be the auriculo-jugular and auriculo-subclavian bypasses, which can reduce the relative risk of post-operative complications by a factor of the risk of lethal by a factor of 3.5
胸腺肿瘤手术策略的特点
本研究的目的:研究胸腺肿瘤手术治疗的回顾性分析结果,以预测长期结果。方法。研究纳入了2019年9月至2021年5月在胸腹外科接受治疗的35例患者。对照组20例SVCS患者采用常规技术治疗,实验组15例患者采用我们开发的新型搭桥手术治疗。结果。静脉旁路必须辅以细胞减少术。实验组术后并发症包括耳锁骨下搭桥血栓形成,对照组术后并发症包括胸骨切口出血1例(3.3%),上腔静脉血栓形成2例(6.6%),肺炎2例(6.6%)。计算两组患者并发症和致死结果的相对风险。结果发现,对照组发生并发症的风险是实验组的2倍(相对风险标准误差为0.64)。结论。胸腺瘤伴SVC侵袭患者根治性手术的第一步必须是耳-颈静脉搭桥和耳-锁骨下搭桥,这可以将术后并发症的相对风险降低到致死风险的3.5倍
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
4 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信